Borte, Michael <br/><br/>
Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter study.  [electronic resource] 

 -  Journal of clinical immunology  Dec 2011 
 - 952-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-2592 
<br/><br/><label>Standard No.: </label>10.1007/s10875-011-9588-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Anti-Infective Agents--administration & dosage<br/>Child<br/>Child, Preschool<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoglobulin G--blood<br/>Immunoglobulins--administration & dosage<br/>Immunoglobulins, Intravenous--administration & dosage<br/>Immunologic Deficiency Syndromes--blood<br/>Infant<br/>Injections, Subcutaneous<br/>Italy<br/>Male<br/>Middle Aged<br/>Prospective Studies